TAK-220

TAK-220
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16973-5mg 5 mg

7 - 10 business days*

345.00€
TGM-T16973-1mL 1 ml

7 - 10 business days*

380.00€
TGM-T16973-25mg 25 mg

7 - 10 business days*

1,140.00€
TGM-T16973-50mg 50 mg

7 - 10 business days*

1,490.00€
TGM-T16973-100mg 100 mg

7 - 10 business days*

1,991.00€
 
Description: TAK-220 is a selective and orally bioavailable CCR5 antagonist with IC50 values of... more
Product information "TAK-220"
Description: TAK-220 is a selective and orally bioavailable CCR5 antagonist with IC50 values of 3.5 nM for RANTES binding inhibition and 1.4 nM for MIP-1alpha binding inhibition to CCR5. Target: HIV Protease. Smiles: CC(=O)N1CCC(CC1)C(=O)N(CCCN1CCC(Cc2ccc(cc2)C(N)=O)CC1)c1ccc(C)c(Cl)c1. References: Takashima K, et al. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist. Antimicrob Agents Chemother. 2005 Aug,49(8):3474-82.
Supplier: TargetMol
Supplier-Nr: T16973

Properties

Application: CCR5 antagonist
MW: 553.14 D
Formula: C31H41ClN4O3

Database Information

CAS : 333994-00-6| Matching products
KEGG ID : K04180 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "TAK-220"
Write a review
or to review a product.
Viewed